Company Filing History:
5 out of 676 
2 out of 2,198 
4 out of 832,812 Years Active: 1996-2007
Title: Maxine Gowan: Innovator in Osteoclast Research
Introduction
Maxine Gowan is a prominent inventor based in Valley Forge, PA (US). She has made significant contributions to the field of biomedical research, particularly in the study of osteoclasts and their role in bone diseases. With a total of 9 patents to her name, Gowan's work has the potential to impact therapeutic approaches for conditions such as osteoporosis and cancer.
Latest Patents
One of Gowan's latest patents involves a human osteoclast-derived cathepsin, known as Cathepsin O. This invention discloses a polypeptide and the DNA (RNA) encoding such cathepsin O polypeptides. Additionally, she has provided a procedure for producing this polypeptide through recombinant techniques. The invention also includes antibodies, antagonists, and inhibitors of Cathepsin O, which may be utilized therapeutically to prevent the action of this polypeptide, thereby offering potential treatments for bone diseases and tumor metastases.
Career Highlights
Throughout her career, Maxine Gowan has worked with notable organizations, including Human Genome Sciences, Inc. Her innovative research has positioned her as a key figure in the field of osteoclast biology and therapeutic development.
Collaborations
Gowan has collaborated with esteemed colleagues such as Gregg A Hastings and Mark D Adams, contributing to a rich exchange of ideas and advancements in her research area.
Conclusion
Maxine Gowan's contributions to the field of osteoclast research and her innovative patents highlight her role as a leading inventor in biomedical science. Her work continues to pave the way for new therapeutic strategies in treating bone diseases and cancers.